These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26944947)

  • 1. Flecainide-Responsive Myotonia Permanens With SNEL Onset: A New Case and Literature Review.
    Portaro S; Rodolico C; Sinicropi S; Musumeci O; Valenzise M; Toscano A
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26944947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life.
    Lehmann-Horn F; D'Amico A; Bertini E; Lomonaco M; Merlini L; Nelson KR; Philippi H; Siciliano G; Spaans F; Jurkat-Rott K
    Acta Myol; 2017 Sep; 36(3):125-134. PubMed ID: 29774303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and outcome of SCN4A-related severe neonatal episodic laryngospasm (SNEL): 2 new cases.
    Caietta E; Milh M; Sternberg D; Lépine A; Boulay C; McGonigal A; Chabrol B
    Pediatrics; 2013 Sep; 132(3):e784-7. PubMed ID: 23958773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy.
    Desaphy JF; Modoni A; Lomonaco M; Camerino DC
    Eur J Clin Pharmacol; 2013 Apr; 69(4):1037-9. PubMed ID: 23052413
    [No Abstract]   [Full Text] [Related]  

  • 5. Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation.
    Desaphy JF; Carbonara R; D'Amico A; Modoni A; Roussel J; Imbrici P; Pagliarani S; Lucchiari S; Lo Monaco M; Conte Camerino D
    Neurology; 2016 May; 86(22):2100-8. PubMed ID: 27164696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New phenotype of severe neonatal episodic laryngospasm due to a missense mutation in SCN4A: A case report and literature review.
    Xi Q; Yi L; Zhou W; Chen J; Yang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1430-1436. PubMed ID: 35232915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal and abnormally persistent paralysis associated with congenital paramyotonia.
    Magot A; David A; Sternberg D; Péréon Y
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24939454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New phenotype and neonatal onset of sodium channel myotonia in a child with a novel mutation of SCN4A gene.
    Fusco C; Frattini D; Salerno GG; Canali E; Bernasconi P; Maggi L
    Brain Dev; 2015 Oct; 37(9):891-3. PubMed ID: 25735906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines on clinical presentation and management of nondystrophic myotonias.
    Stunnenberg BC; LoRusso S; Arnold WD; Barohn RJ; Cannon SC; Fontaine B; Griggs RC; Hanna MG; Matthews E; Meola G; Sansone VA; Trivedi JR; van Engelen BGM; Vicart S; Statland JM
    Muscle Nerve; 2020 Oct; 62(4):430-444. PubMed ID: 32270509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia.
    Campanale C; Laghetti P; Saltarella I; Altamura C; Canioni E; Iosa E; Maggi L; Brugnoni R; Tacconi P; Desaphy JF
    J Neuromuscul Dis; 2024; 11(3):725-734. PubMed ID: 38427496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical comparison and functional study of the L703P: a recurrent mutation in human SCN4A that causes sodium channel myotonia.
    Ke Q; Zhao Y; Li Y; Ye J; Tang S; He F; Ji F; Dai X; Ni J; Li Y; Griggs RC; Cheng X
    Neuromuscul Disord; 2022 Oct; 32(10):811-819. PubMed ID: 36050252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate.
    Farinato A; Altamura C; Imbrici P; Maggi L; Bernasconi P; Mantegazza R; Pasquali L; Siciliano G; Lo Monaco M; Vial C; Sternberg D; Carratù MR; Conte D; Desaphy JF
    Pharmacol Res; 2019 Mar; 141():224-235. PubMed ID: 30611854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-dystrophic myotonia Chilean cohort with predominance of the SCN4A Gly1306Glu variant.
    Avila-Smirnow D; Vargas Leal CP; Beytía Reyes MLA; Cortés Zepeda R; Escobar RG; Kleinsteuber Saa K; Lagos Lucero M; Avaria Benapres MLA; Padilla Pérez O; Casar Leturia JC; Mellado Sagredo C; Sternberg D
    Neuromuscul Disord; 2020 Jul; 30(7):554-561. PubMed ID: 32593548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe neonatal non-dystrophic myotonia secondary to a novel mutation of the voltage-gated sodium channel (SCN4A) gene.
    Gay S; Dupuis D; Faivre L; Masurel-Paulet A; Labenne M; Colombani M; Soichot P; Huet F; Hainque B; Sternberg D; Fontaine B; Gouyon JB; Thauvin-Robinet C
    Am J Med Genet A; 2008 Feb; 146A(3):380-3. PubMed ID: 18203179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.
    Trivedi JR; Bundy B; Statland J; Salajegheh M; Rayan DR; Venance SL; Wang Y; Fialho D; Matthews E; Cleland J; Gorham N; Herbelin L; Cannon S; Amato A; Griggs RC; Hanna MG; Barohn RJ;
    Brain; 2013 Jul; 136(Pt 7):2189-200. PubMed ID: 23771340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo variant in SCN4A causes neonatal sodium channel myotonia with general muscle stiffness and respiratory failure.
    Pechmann A; Eckenweiler M; Schorling D; Stavropoulou D; Lochmüller H; Kirschner J
    Neuromuscul Disord; 2019 Nov; 29(11):907-909. PubMed ID: 31732390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.
    Desaphy JF; De Luca A; Didonna MP; George AL; Camerino Conte D
    J Physiol; 2004 Jan; 554(Pt 2):321-34. PubMed ID: 14608015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel De Novo Heterozygous SCN4a Mutation Causing Congenital Myopathy, Myotonia and Multiple Congenital Anomalies.
    Waldrop M; Amornvit J; Pierson CR; Boue DR; Sahenk Z
    J Neuromuscul Dis; 2019; 6(4):467-473. PubMed ID: 31609695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in SCN4A: a rare but treatable cause of recurrent life-threatening laryngospasm.
    Singh RR; Tan SV; Hanna MG; Robb SA; Clarke A; Jungbluth H
    Pediatrics; 2014 Nov; 134(5):e1447-50. PubMed ID: 25311598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying a life-threatening skeletal muscle Na+ channel disorder.
    Simkin D; Léna I; Landrieu P; Lion-François L; Sternberg D; Fontaine B; Bendahhou S
    J Physiol; 2011 Jul; 589(Pt 13):3115-24. PubMed ID: 21521764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.